Literature DB >> 28879853

dCas9: A Versatile Tool for Epigenome Editing.

Daan J W Brocken1, Mariliis Tark-Dame2, Remus T Dame3.   

Abstract

The epigenome is a heritable layer of information not encoded in the DNA sequence of the genome, but in chemical modifications of DNA or histones. These chemical modifications, together with transcription factors, operate as spatiotemporal regulators of genome activity. Dissecting epigenome function requires controlled site-specific alteration of epigenetic information. Such control can be obtained using designed DNA-binding platforms associated with effector domains to function as targeted transcription factors or epigenetic modifiers. Here, we review the use of dCas9 as a novel and versatile tool for fundamental studies on epigenetic landscapes, chromatin structure and transcription regulation, and the potential of this approach in basic research in these fields.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28879853     DOI: 10.21775/cimb.026.015

Source DB:  PubMed          Journal:  Curr Issues Mol Biol        ISSN: 1467-3037            Impact factor:   2.081


  23 in total

Review 1.  Progress in Epigenetics of Depression.

Authors:  Catherine J Peña; Eric J Nestler
Journal:  Prog Mol Biol Transl Sci       Date:  2018-04-10       Impact factor: 3.622

Review 2.  Regulation of transposable elements by DNA modifications.

Authors:  Özgen Deniz; Jennifer M Frost; Miguel R Branco
Journal:  Nat Rev Genet       Date:  2019-07       Impact factor: 53.242

Review 3.  Regulating CRISPR/Cas9 Function through Conditional Guide RNA Control.

Authors:  Wes Brown; Wenyuan Zhou; Alexander Deiters
Journal:  Chembiochem       Date:  2020-11-17       Impact factor: 3.164

4.  Mechanisms Contributing to the Dysregulation of miRNA-124 in Pulmonary Hypertension.

Authors:  Hui Zhang; Aya Laux; Kurt R Stenmark; Cheng-Jun Hu
Journal:  Int J Mol Sci       Date:  2021-04-08       Impact factor: 5.923

Review 5.  CRISPR/Cas9 ribonucleoprotein-mediated genome and epigenome editing in mammalian cells.

Authors:  Hanan Bloomer; Jennifer Khirallah; Yamin Li; Qiaobing Xu
Journal:  Adv Drug Deliv Rev       Date:  2021-12-20       Impact factor: 15.470

6.  A Method to Reduce off-Targets in CRISPR/Cas9 System in Plants.

Authors:  Ali Movahedi; Zahra Hajiahmadi; Hui Wei; Liming Yang; Honghua Ruan; Qiang Zhuge
Journal:  Methods Mol Biol       Date:  2022

7.  A CRISPR-Cas9 repressor for epigenetic silencing of KRAS.

Authors:  Jingwen Liu; Meiyan Sun; Kwang Bog Cho; Xiang Gao; Bin Guo
Journal:  Pharmacol Res       Date:  2020-11-14       Impact factor: 7.658

8.  Unexpected binding behaviors of bacterial Argonautes in human cells cast doubts on their use as targetable gene regulators.

Authors:  Henriette O'Geen; Chonghua Ren; Nicole B Coggins; Sofie L Bates; David J Segal
Journal:  PLoS One       Date:  2018-03-27       Impact factor: 3.240

9.  Comprehensive off-target analysis of dCas9-SAM-mediated HIV reactivation via long noncoding RNA and mRNA profiling.

Authors:  Yonggang Zhang; Gustavo Arango; Fang Li; Xiao Xiao; Raj Putatunda; Jun Yu; Xiao-Feng Yang; Hong Wang; Layne T Watson; Liqing Zhang; Wenhui Hu
Journal:  BMC Med Genomics       Date:  2018-09-10       Impact factor: 3.063

Review 10.  CRISPR/Cas based gene editing: marking a new era in medical science.

Authors:  Kirti Prasad; Anila George; Nithin Sam Ravi; Kumarasamypet M Mohankumar
Journal:  Mol Biol Rep       Date:  2021-06-18       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.